Status:

COMPLETED

Better Nights, Better Days for Typically Developing Children

Lead Sponsor:

IWK Health Centre

Conditions:

Nonorganic Insomnia

Primary Insomnia

Eligibility:

All Genders

1-10 years

Phase:

NA

Brief Summary

Up to 25% of children suffer from sleep problems categorized as "insomnia": difficulty settling, falling asleep, and staying asleep. This leads to daytime sleepiness and negatively effects behaviour, ...

Detailed Description

Rationale: Evidence demonstrates that behavioural interventions should be the first line of treatment for children with insomnia, but this is not typically the case. Evidence-based behavioural interv...

Eligibility Criteria

Inclusion

  • Potential participants must meet the following criteria to be eligible to participate in the study:
  • Primary caregiver of a child aged 1 to 10 years.
  • Live in any province or territory in Canada.
  • Have regular access to high speed internet connection and an email account.
  • Comfortable communicating in English or French for day-to-day tasks (e.g., listening to the news on the radio or watching TV, reading books, magazines, etc.).
  • Child has insomnia, defined as having Sleep Onset Disturbance. For Sleep Onset Disturbance, child must meet two of the following three criteria. These episodes must have been occurring for at least one month:
  • 1\. More than three reunions for 12-24 month olds/more than two reunions for \>24 month olds that occur two or more nights per week 2. 30 or more minutes to fall asleep for 12-24 month olds/20 or more minutes to fall asleep for \>24 month olds 3. Parent remains in room for sleep onset for two or more nights per week

Exclusion

  • Potential participants who meet any of the following criteria are not eligible to participate in the study:
  • Parent wishes to "bed-share" with his/her child.
  • Child has a probable intrinsic sleep disorder (e.g., sleep apnea) as assessed using the Pediatric Sleep Questionnaire (PSQ).
  • Child has a significant medical disorder that interferes with sleep (e.g., asthma attacks during night, tube feeding, non-ambulatory, severe developmental disability affecting sensory systems such as vision).
  • Child has a mental health disorder that has required hospitalization or residential care and/or current use of psychotropic medications which are known to interfere with sleep (e.g., stimulant medication for ADHD).

Key Trial Info

Start Date :

September 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2018

Estimated Enrollment :

534 Patients enrolled

Trial Details

Trial ID

NCT02243501

Start Date

September 1 2016

End Date

October 1 2018

Last Update

April 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dalhousie University

Halifax, Nova Scotia, Canada, B3H 2R1